Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

ABL Bio Licenses Grabody-B Platform to GSK for Brain Drugs

PR Newswire
by PR Newswire0245
ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases Programs will leverage ABL Bio’s Grabody-B platform technology to effectively deliver molecules across...
Clinical Research, Pharma & Healthcare Financing

Alcanza Clinical Research Adds New President and CFO

PR Newswire
by PR Newswire0249
Alcanza Clinical Research, a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, announces the appointment of Karim Chalhoub as President and Chief Operating...
Clinical Research, Pharma & Healthcare Financing

MOASC Honors Young Investigator, Advancing Oncology Research

PR Newswire
by PR Newswire0135
Dr. Peter Zang receives the 2025 Cary Presant, MD Young Investigator Award for his groundbreaking research on metastatic castrate-resistant prostate cancer, improving treatment strategies and patient outcomes....
Clinical Research, Pharma & Healthcare Financing

AscellaHealth Q1 2025 Specialty & Rare Pipeline Digest™

GlobeNewswire
by GlobeNewswire0190
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty & Rare Pipeline Digest™, the industry’s most comprehensive digital...
Clinical Research, Pharma & Healthcare Financing

Boehringer Ingelheim Expands ADC Portfolio with Basel R&D Center

GlobeNewswire
by GlobeNewswire0196
Today NBE Therapeutics (NBE) a wholly owned subsidiary of  Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint in Switzerland’s biotech ecosystem. NBE Therapeutics, a Swiss biotech founded in 2012 that...
Clinical Research, Pharma & Healthcare Financing

Artis BioSolutions Acquires Landmark Bio, Emerges from Stealth

Business Wire
by Business Wire0200
Landmark acquisition positions Artis to revolutionize advanced therapy manufacturing and commercialization Artis BioSolutions, a company founded to streamline the discovery, development and production of genetic...
Clinical Research, Pharma & Healthcare Financing

Palleon Announces NMPA IND Clearance for Phase 2 Trial of E-602

Business Wire
by Business Wire0278
Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced that the China National Medical Products Administration (NMPA) has...
Clinical Research, Pharma & Healthcare Financing

MultiOmic Health & Alloy Therapeutics Partner on Renal Drugs

Business Wire
by Business Wire0181
The collaboration provides external validation of MultiOmic Health’s AI-enabled precision medicine discovery platform and innovative renal therapeutic programs MultiOmic Health Limited (“MOH”), an artificial intelligence (AI)-enabled...
Clinical Research, Pharma & Healthcare Financing

NYU Langone Health Names Alec C. Kimmelman, MD, PhD as Next CEO and Dean

PR Newswire
by PR Newswire0297
Renowned Radiation Oncologist and Director of Laura and Isaac PerlmutterCancer Center, Dr. Kimmelman will succeed retiring CEO and DeanRobert I. Grossman, MD, on September 1 Following an...
Clinical Research, Pharma & Healthcare Financing

Savara Secures Up to $200M Non-Dilutive Debt Financing

Business Wire
by Business Wire0279
Includes $30M at Close to Refinance Existing Debt Facility Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today...
Clinical Research, Pharma & Healthcare Financing

Celltrion’s Remdantry™ to launch in Canada on April 1, 2025

Business Wire
by Business Wire0198
Celltrion, Inc., a leading global biopharmaceutical company, announced that Remdantry™ will be available in Canada as of April 1, 2025. Remdantry™, previously known as Inflectra®,...
Clinical Research, Pharma & Healthcare Financing

Health Canada Approves 4Moving Biotech’s Phase 2a OA Trial

Business Wire
by Business Wire0174
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify the natural history of knee osteoarthritis, announces that it has been...